Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Spekulatius who wrote (8638)	11/19/2004 12:16:31 AM
From: Stephen O	Respond to of 9523

I have no medical training, just a good inquisitive mind. I've read lots over the past year about the statin drugs. The comments from the FDA's Graham have great credibility with me. The drug companies really like to get positive test results by hook or by crook and get a drug on the market. They then market them unethically to build market share. It would not surprise me that Merck pulled Vioxx because a spy in the FDA told them to. Crestor is just too strong, works way to effectively in reducing cholesterol but what else does it do. Baycol is a statin that has already been pulled. If statins are a class too then watch out for Lipitor. I can see the drugs being very restrictive in their use, perhaps 10% of what are currently sold. I'd believe the FDA's Graham over any drug company executive.